Skip to content
Open access

Glycometabolic, inflammatory and exocrine plasma proteins predict cancer in individuals with cardiovascular disease

Sep 2026 · bioRxiv · 0 citations
Biology

TL;DR

Whether a minimal circulating-protein signature anticipates incident cancer in patients with atheromatous cardiovascular disease exposed to tobacco is asked and estimates are conditional on the cancer frequency of this population, conditional on the cancer frequency of this population.

Read PDF

Similar papers

Open access Sep 2026

Circulating PCSK9: A new frontier in cancer risk stratification for obese diabetics.

This study investigated potential plasma biomarkers associated with cancer risk and mortality in patients with type 2 diabetes mellitus (T2DM), a population known to have an increased cancer incidence and poorer outcomes compared with non-diabetic individuals. Traditional metabolic indicators, including blood pressure,...

Lien-Cheng Tsao, Chen-Ling Kuo, Yu-Shan Cheng et al. · 0 citations
Open access Sep 2026

Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality.

PIS provides a compact, interpretable proteomic measure of inflammaging and captures mortality, multisystem disease burden, and aging-related biology in population-scale cohorts.

Zhou Jiang, Dan-Yang Ling, Zi-Wei Chen et al. · 0 citations
Open access Sep 2026

Population-scale plasma proteomics reveals pre-diagnostic biomarkers and shared pathways of cancer risk across 25 cancers

Abstract The causes of most cancers remain unknown because the biological pathways underlying cancer development are poorly understood. Large-scale plasma proteomics offers a powerful strategy to uncover these pathways, identify biomarkers for cancer early detection, and discover novel therapeutic targets but has rarel...

J. Yarmolinsky, V. Viallon, V. Burk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.